<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nichols, Emma Hitt</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Gold, Michael R.</style></author><author><style face="normal" font="default" size="100%">Awad, Khaled A.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">New ICDs Safe, Effective After MRI in Evera MRI and ProMRI Studies</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-07-02 10:57:42</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">5-6</style></pages><abstract><style  face="normal" font="default" size="100%">Two new implantable cardioverter defibrillator systems developed for compatibility with magnetic resonance imaging demonstrate safety and efficacy in the Evera MRI and ProMRI trials, with no significant changes in ventricular pacing threshold &lt; 5.0 V or ventricular sensing. In addition, there were no serious device-related events in both studies.</style></abstract><number><style face="normal" font="default" size="100%">12</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>